Andy Bader

Andy Bader

Company: Triumvira Immunologics

Job title: Chief Scientific Officer


Dr. Andreas Bader is Chief Scientific Officer at Triumvira Immunologics Inc. and has ~25 years’ experience in cancer research and oncology drug-discovery and development. Previously, Dr. Bader acted as Co-Founder and CEO of Orros Biotherapeutics LLC, and as a scientific Co-Founder of Mirna Therapeutics Inc., where he held multiple leading positions in R&D and led research programs from discovery to the completion of a Phase 1 clinical trial. Dr. Bader completed his post-doctoral training at The Scripps Research Institute, La Jolla, California, and received his PhD in Biochemistry and his MSc degree in Biology from the University of Innsbruck, Austria.


Live Presenter Q&A 3:10 pm

Read more

day: Day One

T Cells Engineered With the T Cell Antigen Coupler (TAC) to Treat HER2-Positive Solid Tumors 2:50 pm

• The TAC technology leverages endogenous T cell signaling for more efficacious and safer T cell applications • Autologous and allogeneic TAC T cells effectively eliminate HER2+ tumor cells in preclinical studies • Initiation of a first-in-human clinical trialRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.